• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤化疗中抗耐药性的新兴纳米策略

Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy.

作者信息

Cao Lei, Zhu Yuqin, Wang Weiju, Wang Gaoxiong, Zhang Shuaishuai, Cheng Hongwei

机构信息

Department of Pathology, Quanzhou Women's and Children's Hospital, Quanzhou, China.

Department of Pathology, Qingyuan Maternal and Child Health Hospital, Qingyuan, China.

出版信息

Front Bioeng Biotechnol. 2021 Dec 7;9:798882. doi: 10.3389/fbioe.2021.798882. eCollection 2021.

DOI:10.3389/fbioe.2021.798882
PMID:34950650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8688801/
Abstract

Drug resistance is the most significant causes of cancer chemotherapy failure. Various mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment, changes at cellular levels, genetic factors, and other mechanisms. In recent years, more attention has been paid to tumor resistance mechanisms and countermeasures. Nanomedicine is an emerging treatment platform, focusing on alternative drug delivery and improved therapeutic effectiveness while reducing side effects on normal tissues. Here, we reviewed the principal forms of drug resistance and the new possibilities that nanomaterials offer for overcoming these therapeutic barriers. Novel nanomaterials based on tumor types are an excellent modality to equalize drug resistance that enables gain more rational and flexible drug selectivity for individual patient treatment. With the emergence of advanced designs and alternative drug delivery strategies with different nanomaterials, overcome of multidrug resistance shows promising and opens new horizons for cancer therapy. This review discussed different mechanisms of drug resistance and recent advances in nanotechnology-based therapeutic strategies to improve the sensitivity and effectiveness of chemotherapeutic drugs, aiming to show the advantages of nanomaterials in overcoming of drug resistance for tumor chemotherapy, which could accelerate the development of personalized medicine.

摘要

耐药性是癌症化疗失败的最主要原因。耐药的各种机制包括肿瘤异质性、肿瘤微环境、细胞水平变化、遗传因素及其他机制。近年来,人们对肿瘤耐药机制及应对措施给予了更多关注。纳米医学是一个新兴的治疗平台,专注于替代药物递送并提高治疗效果,同时减少对正常组织的副作用。在此,我们综述了耐药的主要形式以及纳米材料为克服这些治疗障碍所带来的新可能性。基于肿瘤类型的新型纳米材料是一种平衡耐药性的极佳方式,能够为个体患者治疗实现更合理、灵活的药物选择性。随着先进设计以及不同纳米材料的替代药物递送策略的出现,克服多药耐药显示出前景,并为癌症治疗开辟了新视野。本综述讨论了耐药的不同机制以及基于纳米技术的治疗策略的最新进展,以提高化疗药物的敏感性和有效性,旨在展示纳米材料在克服肿瘤化疗耐药性方面的优势,这可加速个性化医学的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/78a21b13a743/fbioe-09-798882-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/00fd0d35177a/fbioe-09-798882-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/2414b620986a/fbioe-09-798882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/11a2d1b82931/fbioe-09-798882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/281f27b27f16/fbioe-09-798882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/ddd0c8312a87/fbioe-09-798882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/5fc98a835c02/fbioe-09-798882-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/0806f99a2778/fbioe-09-798882-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/80aa6cb235e2/fbioe-09-798882-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/c3b6abf6be3b/fbioe-09-798882-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/78a21b13a743/fbioe-09-798882-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/00fd0d35177a/fbioe-09-798882-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/2414b620986a/fbioe-09-798882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/11a2d1b82931/fbioe-09-798882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/281f27b27f16/fbioe-09-798882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/ddd0c8312a87/fbioe-09-798882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/5fc98a835c02/fbioe-09-798882-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/0806f99a2778/fbioe-09-798882-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/80aa6cb235e2/fbioe-09-798882-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/c3b6abf6be3b/fbioe-09-798882-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/8688801/78a21b13a743/fbioe-09-798882-g009.jpg

相似文献

1
Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy.肿瘤化疗中抗耐药性的新兴纳米策略
Front Bioeng Biotechnol. 2021 Dec 7;9:798882. doi: 10.3389/fbioe.2021.798882. eCollection 2021.
2
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.新兴纳米技术治疗药物对抗多药耐药性癌症。
J Nanobiotechnology. 2022 Sep 24;20(1):423. doi: 10.1186/s12951-022-01626-z.
3
Nanomedicine therapeutic approaches to overcome cancer drug resistance.纳米医学治疗方法克服癌症药物耐药性。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1866-79. doi: 10.1016/j.addr.2013.09.019. Epub 2013 Oct 10.
4
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system.纳米载体药物递送系统在克服癌症耐药性方面的最新进展。
Cancer Drug Resist. 2023 Jun 20;6(2):390-415. doi: 10.20517/cdr.2023.16. eCollection 2023.
5
Novel nanomedicines to overcome cancer multidrug resistance.新型纳米药物克服癌症多药耐药性。
Drug Resist Updat. 2021 Sep;58:100777. doi: 10.1016/j.drup.2021.100777. Epub 2021 Aug 4.
6
Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.用于应对多药耐药中癌细胞生物学的纳米医学
Mini Rev Med Chem. 2017;17(18):1793-1810. doi: 10.2174/1389557516666160219123222.
7
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.癌症治疗的靶向纳米医学:迈向克服耐药性的精准医学。
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
8
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.靶向肿瘤微环境以克服耐药性的治疗药物纳米制剂的当前进展。
Cancer Metastasis Rev. 2023 Sep;42(3):959-1020. doi: 10.1007/s10555-023-10119-w. Epub 2023 Jul 28.
9
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine.纳米金刚石:纳米技术、药物研发与个性化医疗的交叉领域。
Sci Adv. 2015 Aug 21;1(7):e1500439. doi: 10.1126/sciadv.1500439. eCollection 2015 Aug.
10
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.纳米技术在克服癌症治疗中的多药耐药性中的作用:综述。
Molecules. 2022 Oct 5;27(19):6608. doi: 10.3390/molecules27196608.

引用本文的文献

1
Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance.癌症治疗中的纳米技术:革新抗耐药性策略
Front Bioeng Biotechnol. 2025 Apr 30;13:1548588. doi: 10.3389/fbioe.2025.1548588. eCollection 2025.
2
Recent advances in the role of circRNA in cisplatin resistance in tumors.环状RNA在肿瘤顺铂耐药中作用的最新进展
Cancer Gene Ther. 2025 May;32(5):497-506. doi: 10.1038/s41417-025-00899-4. Epub 2025 Mar 27.
3
Recent Advances in Polysaccharide-Based Hydrogels for Tumor Immunotherapy.用于肿瘤免疫治疗的多糖基水凝胶的最新进展

本文引用的文献

1
Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.负载可裂解蛋白的基质金属蛋白酶响应性介孔二氧化硅纳米颗粒用于癌症治疗的“自驱动”按需控制药物递送
ACS Appl Bio Mater. 2020 Aug 17;3(8):4987-4999. doi: 10.1021/acsabm.0c00497. Epub 2020 Jul 10.
2
Dual Tumor Microenvironment Remodeling by Glucose-Contained Radical Copolymer for MRI-Guided Photoimmunotherapy.基于含葡萄糖的自由基共聚物的双重肿瘤微环境重塑用于 MRI 引导的光免疫治疗。
Adv Mater. 2022 Jun;34(25):e2107674. doi: 10.1002/adma.202107674. Epub 2021 Nov 17.
3
Gels. 2025 Feb 20;11(3):152. doi: 10.3390/gels11030152.
4
Impact of UV-Irradiated Mesoporous Titania Nanoparticles (mTiNPs) on Key Onco- and Tumor Suppressor microRNAs of PC3 Prostate Cancer Cells.紫外线照射的介孔二氧化钛纳米颗粒(mTiNPs)对PC3前列腺癌细胞关键致癌和抑癌微小RNA的影响
Genes (Basel). 2025 Jan 25;16(2):148. doi: 10.3390/genes16020148.
5
The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors.ATP结合盒(ABC)转运蛋白家族对头颈肿瘤多药耐药性的影响。
Mol Biol Rep. 2025 Feb 21;52(1):256. doi: 10.1007/s11033-025-10321-9.
6
Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations.基于水凝胶的纳米颗粒:革新脑肿瘤治疗并为未来创新铺平道路。
Eur J Med Res. 2025 Feb 4;30(1):71. doi: 10.1186/s40001-025-02310-2.
7
Application of nanomaterials in precision treatment of lung cancer.纳米材料在肺癌精准治疗中的应用。
iScience. 2024 Dec 26;28(1):111704. doi: 10.1016/j.isci.2024.111704. eCollection 2025 Jan 17.
8
Maytansinoids in cancer therapy: advancements in antibody-drug conjugates and nanotechnology-enhanced drug delivery systems.美登素类药物在癌症治疗中的应用:抗体-药物偶联物及纳米技术增强药物递送系统的进展
Discov Oncol. 2025 Jan 21;16(1):73. doi: 10.1007/s12672-025-01820-z.
9
Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998-2024).肺癌纳米药物递送系统的全球研究趋势与新兴热点:一项全面的文献计量分析(1998 - 2024年)
Discov Oncol. 2025 Jan 11;16(1):33. doi: 10.1007/s12672-025-01782-2.
10
Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies.碳纳米材料作为抗癌药物阿霉素的载体:理论与实验研究综述
Nanoscale Adv. 2024 Apr 26;6(16):3992-4014. doi: 10.1039/d4na00278d. eCollection 2024 Aug 6.
Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer.
基于酶可转化聚合物囊泡的纳米治疗药物,以消除最小复发癌症。
Adv Mater. 2021 Dec;33(49):e2105254. doi: 10.1002/adma.202105254. Epub 2021 Oct 7.
4
SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer.SIRT1/PGC-1α/PPAR-γ与非小细胞肺癌中缺氧诱导的化疗耐药相关。
Front Oncol. 2021 Jul 26;11:682762. doi: 10.3389/fonc.2021.682762. eCollection 2021.
5
Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis.介孔二氧化硅纳米颗粒通过 TLR4-NFκB 轴使肿瘤炎症,从而克服抗 PD-1 耐药性。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002508.
6
Sex as an important factor in nanomedicine.性在纳米医学中的重要作用。
Nat Commun. 2021 May 20;12(1):2984. doi: 10.1038/s41467-021-23230-9.
7
injection of dual-delivery PEG based MMP-2 sensitive hydrogels for enhanced tumor penetration and chemo-immune combination therapy.注射基于双重递送 PEG 的 MMP-2 敏感水凝胶以增强肿瘤穿透和化疗免疫联合治疗。
Nanoscale. 2021 Jun 3;13(21):9577-9589. doi: 10.1039/d1nr01155c.
8
Cyclodextrin-Based Hybrid Polymeric Complex to Overcome Dual Drug Resistance Mechanisms for Cancer Therapy.基于环糊精的杂化聚合物复合物用于克服癌症治疗中的双重耐药机制
Polymers (Basel). 2021 Apr 13;13(8):1254. doi: 10.3390/polym13081254.
9
Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicine.利用缺氧扩增型 DNA 修复抑制(HYDRI)纳米药物来利用顺铂耐药肿瘤的获得性脆弱性。
Sci Adv. 2021 Mar 26;7(13). doi: 10.1126/sciadv.abc5267. Print 2021 Mar.
10
A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting.一种使用酶敏感纳米平台的联合化学免疫疗法,通过级联靶向将双药递送至特定部位。
Sci Adv. 2021 Feb 5;7(6). doi: 10.1126/sciadv.aba0776. Print 2021 Feb.